Akoya Biosciences Inc. (AKYA)
NASDAQ: AKYA
· Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jul 07, 2025, 3:59 PM
Akoya Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -47.53M | -55.37M | -57.97M | -60.35M | -68M | -63.32M | -71.4M | -76.35M | -73.04M | -70.64M | -69.44M | -63.18M | -51.25M | -42.94M | -30.96M | -23.62M | -22.64M |
Depreciation & Amortization | 7.4M | 7.65M | 7.91M | 8.66M | 8.82M | 8.89M | 8.69M | 8.05M | 7.65M | 7.15M | 6.62M | 5.93M | 5.37M | 4.79M | 4.44M | 4.17M | 3.96M |
Stock-Based Compensation | 8.99M | 9.31M | 9.72M | 10.72M | 10.63M | 10.44M | 9.99M | 9.16M | 8.26M | 7.43M | 6.72M | 5.83M | 5.33M | 4.04M | 2.68M | 1.58M | 419K |
Other Working Capital | 14.1M | 11.08M | 9.95M | -1.78M | -3.86M | -1.39M | 3M | 9.19M | 9.01M | 6.63M | 7.24M | 266K | -4.1M | -1.32M | -6.1M | -3.52M | -1.02M |
Other Non-Cash Items | -12.43M | 5.65M | 5.95M | 24.09M | 24.71M | 7.03M | 6.61M | 3.41M | 462K | 367K | 835K | 689K | 655K | 2.75M | 4.41M | 5.01M | 6.95M |
Deferred Income Tax | -22K | 4K | 24K | -2.21M | -19K | -56K | -69K | 2.13M | 25K | 35K | -20K | -40K | -135K | -155K | -77K | -68K | -30K |
Change in Working Capital | 8.72M | 506K | -452K | -20.22M | -16.2M | -13.84M | -9.14M | -136K | 1.32M | 2.16M | 5.94M | 206K | -9.56M | -4.56M | -12.86M | -7.78M | 1.06M |
Operating Cash Flow | -30.49M | -44.1M | -46.67M | -51.17M | -51.93M | -50.87M | -55.32M | -53.74M | -55.32M | -53.5M | -49.34M | -50.57M | -49.6M | -36.07M | -32.36M | -20.71M | -10.29M |
Capital Expenditures | -1.85M | -2.46M | -2.01M | -2.41M | -3.66M | -3.65M | -3.93M | -6.88M | -7.03M | -7.36M | -7.86M | -5.94M | -5.33M | -5.09M | -4.22M | -3.2M | -2.81M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 55K | 55K | 55K | 55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -60.04M | -104.29M | -87.33M | -69.78M | -48.01M | n/a | -23.05M | -23.05M | -63.83M | -63.83M | -40.77M | -40.77M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 102.7M | 82.7M | 62M | 31M | n/a | 7M | 30M | 41.05M | 41.05M | 34.05M | 11.05M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -48.01M | -48.01M | -48.01M | -48.01M | 7M | 30M | 41.05M | 281K | -6.72M | -29.72M | -40.77M | n/a | n/a | 10.14M | 10.1M | 10.06M |
Investing Cash Flow | 40.81M | -24.05M | -27.34M | -41.19M | -51.67M | 3.35M | 26.07M | 34.17M | -6.75M | -14.08M | -37.58M | -46.72M | -5.33M | -5.09M | 5.92M | 6.9M | 7.26M |
Debt Repayment | -841K | -1.02M | 10.55M | 10.54M | 10.54M | 10.57M | 10.59M | 20.62M | 30.61M | 30.63M | 19.47M | 9.54M | -400K | -322K | 7.2M | 7.23M | 9.77M |
Common Stock Repurchased | 149K | n/a | 94K | -120K | -55K | n/a | -94K | -94K | -94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.44M | -1.44M | -1.44M | -2.63M | -1.19M | -1.19M | -1.19M |
Other Financial Acitivies | -1.99M | -2.18M | -2.2M | -2.18M | 46.27M | 46.26M | 45.45M | 45.41M | -2.23M | -1.9M | -865K | -837K | 137.37M | 137.36M | 135.37M | 135.43M | -1.63M |
Financial Cash Flow | -3.01M | -3.21M | 8.32M | 8.33M | 56.79M | 56.81M | 56.04M | 66.04M | 28.38M | 28.73M | 18.61M | 8.7M | 136.97M | 137.03M | 142.57M | 142.66M | 8.14M |
Net Cash Flow | 7.31M | -71.36M | -66.06M | -84.39M | -47.18M | 8.92M | 26.79M | 46.47M | -33.69M | -38.85M | -68.31M | -88.58M | 82.05M | 95.87M | 116.14M | 128.85M | 5.11M |
Free Cash Flow | -32.34M | -46.56M | -48.68M | -53.58M | -55.59M | -54.52M | -59.25M | -60.63M | -62.35M | -60.86M | -57.2M | -56.51M | -54.92M | -41.16M | -36.58M | -23.91M | -13.1M |